Oculis Holding Ag News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oculis holding ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oculis Holding Ag Today - Breaking & Trending Today

Oculis to Participate at Upcoming April Investor

ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company. ....

Noord Holland , United States , Corey Davis , Sylvia Cheung , Oculis Holding Ag Nasdaq , Van Lanschot Kempen Life Sciences Conference , Riad Sherif , Chief Executive , Nasdaq Ocs , Oculis Holding Ag ,

Positive Phase 3 Stage 1 DIAMOND Trial Results of OCS-01 in Diabetic Macular Edema Presented at 23rd EURETINA Congress

OCS-01’s positive results in Stage 1 of the Phase 3 DIAMOND trial for diabetic macular edema (DME) were presented as a late-breaking abstract showing that the trial met primary and secondary endpoints with robust statistical significanceOn track to commence Stage 2 of the DIAMOND program with two parallel global Phase 3 trialsIf approved, OCS-01 has the potential to become the first topical eye drop for the treatment of DME ZUG, Switzerland and BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) Oculis Ho ....

France General , United States , Noord Holland , Sylvia Cheung , Corey Davis , Ramin Tadayoni , Adolphe De Rothschild Foundation , Oculis Holding Ag Nasdaq , Department Head At Lariboisi , Professor Ramin Tadayoni , Best Corrected Visual Acuity , Paris Cit , Department Head , Saint Louis , Oculi Scientific Advisory Board , Chief Executive Officer , Diabetic Macular Edema , Professor Ramin Tadayoni , Rofessor Tadayoni , Opical Eye Drop , Oculis Holding Ag , Iopharmaceutical Company , Topical Treatment ,

Oculis to Present at Upcoming September Investor Conferences

ZUG, Switzerland, and BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Riad Sherif, MD, Chief Executive Officer, and Sylvia Cheung, Chief Financial Officer will be attending and presenting at the following upcoming investor conferences: H.C. Wainwright 25th Annual Global Investment Conference Format: Company presentation Presentation date and time: ....

New York , United States , Corey Davis , Sylvia Cheung , Oculis Holding Ag Nasdaq , Riad Sherif , Chief Executive Officer , Chief Financial Officer , Annual Global Investment , Annual Healthcare , Oculis Holding Ag , Iopharmaceutical Company , Sylvia Cheung , Chief Executive Officer , Company Presentation , Eye Diseases , Investor Conferences , Corey Davis ,